http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2700904-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd9345fdc7767f7b24226f5bc1984ee1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-30 |
| filingDate | 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed40e13c3b9a46c549c5e659950936c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5688b7da468683e775d015efd32bc90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5dabfe99b17050486fd996c881cc2aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab69d6913c8a43fe2caaa9074ebfa96a |
| publicationDate | 2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2700904-C |
| titleOfInvention | C10-substituted camptothecin analogs |
| abstract | A camptothecin analog for use in the treatment of cancer, said analog having the structural formula: (see above formula) wherein R1 and R2 are selected from the group consisting of: R1 is methoxy and R2 is hydrogen; R1 is methoxymethoxy and R2 is hydrogen; R1 is 3'-hydroxypropoxy and R2 is hydrogen; R1 is 2'-methoxyethoxy and R2 is hydrogen; R1 is isopropoxy and R2 is hydrogen; R1 is ethoxy and R2 is hydroxyl; R1 is amidomethoxy and R2 is hydroxyl; R1 is dimethylcarbamoyloxy and R2 is hydrogen; R1 is ethoxycarbonylmethoxy and R2 is hydrogen; R1 is amidomethyloxy and R2 is hydrogen; R1 is carboxymethyloxy and R2 is hydrogen; R1 is 4-morpholinecarbonyloxy and R2 is hydrogen; R1 is dimethylthiocarbamoyloxy and R2 is hydrogen; R1 is ethoxy and R2 is hydrogen; and R1 is cyanomethoxy and R2 is hydrogen; or a pharmaceutically-acceptable salt thereof. |
| priorityDate | 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.